Vanguard Personalized Indexing Management
GSK icon

Vanguard Personalized Indexing Management’s GSK GSK Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.22M Buy
99,516
+10,608
+12% +$561K 0.04% 354
2026
Q1 		$4.91M Sell
88,908
-3,360
-4% -$182K 0.05% 323
2025
Q4 		$4.52M Buy
92,268
+4,184
+5% +$195K 0.04% 344
2025
Q3 		$3.8M Buy
88,084
+6,015
+7% +$235K 0.04% 380
2025
Q2 		$3.15M Buy
82,069
+397
+0.5% +$15.2K 0.04% 425
2025
Q1 		$3.16M Buy
81,672
+16,748
+26% +$613K 0.05% 352
2024
Q4 		$2.2M Sell
64,924
-3,882
-6% -$140K 0.03% 453
2024
Q3 		$2.81M Buy
68,806
+11,282
+20% +$462K 0.05% 359
2024
Q2 		$2.21M Buy
57,524
+7,011
+14% +$295K 0.04% 377
2024
Q1 		$2.17M Buy
50,513
+11,074
+28% +$457K 0.05% 372
2023
Q4 		$1.46M Buy
39,439
+2,346
+6% +$84.2K 0.04% 459
2023
Q3 		$1.34M Buy
37,093
+2,053
+6% +$72.9K 0.04% 432
2023
Q2 		$1.25M Buy
35,040
+5,060
+17% +$182K 0.04% 467
2023
Q1 		$1.07M Buy
29,980
+8,270
+38% +$289K 0.04% 498
2022
Q4 		$763K Sell
21,710
-476
-2% -$15.9K 0.03% 623
2022
Q3 		$653K Sell
22,186
-4,204
-16% -$159K 0.03% 672
2022
Q2 		$1.44M Buy
26,390
+6,138
+30% +$339K 0.07% 298
2022
Q1 		$1.1M Buy
20,252
+5,493
+37% +$298K 0.05% 401
2021
Q4 		$814K Buy
14,759
+4,648
+46% +$242K 0.05% 496
2021
Q3 		$483K Buy
10,111
+1,119
+12% +$56.2K 0.04% 530
2021
Q2 		$448K Buy
8,992
+968
+12% +$46.5K 0.05% 535
2021
Q1 		$358K Buy
8,024
+619
+8% +$28.1K 0.05% 438
2020
Q4 		$341K Sell
7,405
-2,023
-21% -$92.9K 0.07% 319
2020
Q3 		$444K Buy
9,428
+843
+10% +$42.2K 0.12% 196
2020
Q2 		$438K Buy
+8,585
New +$440K 0.2% 123

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Personalized Indexing Management's GSK Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its GSK (GSK) stake by 12% in Q2 2026, buying an estimated $561K and bringing the position to 99,516 shares worth $5.22M. The position accounts for 0.04% of the portfolio, ranked #354.

Vanguard Personalized Indexing Management first reported a position in GSK in Q2 2020 and has held it in 25 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Vanguard Personalized Indexing Management held 99,516 shares of GSK worth $5.22M as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 10,608 GSK shares in Q2 2026, an estimated $561K.
  • GSK made up 0.04% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #354 holding.
  • Vanguard Personalized Indexing Management first reported a position in GSK in Q2 2020 and has held it in 25 quarters since.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.